Sign in
4/A

Changes in Ownership

Candel Therapeutics, Inc. Filed Acc 0000899243-21-031614

Director bought 1,625,000 shares at $8.00 ($13,000,000)

  • Director acquired 1,232,910 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Manning Paul B · Director

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2021-07-29 Conversion : show line 1 in the form +679,158 679,158 I
2021-07-29 Conversion : show line 2 in the form +553,752 553,752 I
2021-07-29 Purchase : show line 3 in the form +1,625,000 $8.00 $13,000,000 1,681,000 D
Open-market purchases · 1,625,000 sh · avg $8.00 · $13,000,000

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2021-07-29 Conversion : show line 4 in the form Series B Preferred Stock −1,669,303 0 I
2021-07-29 Conversion : show line 5 in the form Series B Preferred Stock −1,361,069 0 I
Loading xslF345X03/doc4a.xml…